NYC Startup Syntimmune Names Former Biogen Exec as New CEO Post author:Sam Post published:January 2, 2018 Post category:BioPharma Syntimmune has appointed Jean-Paul Kress as president and CEO. Source: BioSpace You Might Also Like <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017 How GlaxoSmithKline Lost Nearly $10B in October November 9, 2017 Zomedica Announces First Quarter 2017 Financial Results May 11, 2017
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
